Pfizer Inc. (FRA:PFE)
20.60
-0.06 (-0.29%)
Jun 27, 2025, 9:01 PM CET
Pfizer Employees
Pfizer had 81,000 employees as of December 31, 2024. The number of employees decreased by 7,000 or -7.95% compared to the previous year.
Employees
81,000
Change (1Y)
-7,000
Growth (1Y)
-7.95%
Revenue / Employee
€711,935
Profits / Employee
€89,847
Market Cap
117.87B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81,000 | -7,000 | -7.95% |
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
Pfizer News
- 2 days ago - Pfizer hemophilia therapy succeeds in late-stage trial - Seeking Alpha
- 2 days ago - Pfizer's bleeding disorder therapy meets main goal in patients with certain antibodies - Reuters
- 2 days ago - Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI in Hemophilia A or B with Inhibitors - Wallstreet:Online
- 2 days ago - Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors - Business Wire
- 2 days ago - Heads up: Far-right lawmakers look to table no confidence vote against EU's von der Leyen - Forexlive
- 2 days ago - Pfizer Could Be The Turnaround Story In The Pharmaceutical Space - Seeking Alpha
- 3 days ago - Pfizer declares $0.43 dividend - Seeking Alpha
- 3 days ago - Pfizer Declares Third-Quarter 2025 Dividend - Wallstreet:Online